Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
abscess, intracerebral
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
acute disseminated encephalomyelitis
acute necrotizing encephalitis
adenylate kinase 5 autoantibodies
adverse drug reaction
affect, flat
Alexanders disease
Alexanders disease, adult onset
algorithm
alkylating agents
Alzheimer's disease
amnesia
amphiphysin antibodies
amyloid angiopathy, cerebral
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, misdiagnosis
amyotrophic lateral sclerosis, work up
aneurysm
aneurysm, cavernous sinus
aneurysm, internal carotid artery
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti Hu antibody
antibiotics
antihistamines
arterial dissection, aorta
arteriovenous malformation
arteriovenous malformation, cerebral
ataxia
ataxia, cerebellar
ataxia, progressive
ataxia, truncal
atypical
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autonomic dysfunction
autonomic neuropathy
azathioprine
B 12 deficiency
B cell lymphocytes
Babinski sign
bacterial infection
Barkhof MR criteria for MS
behavioral disorder
Behcet's syndrome
bone marrow biopsy
bone marrow suppression
brain biopsy
brainstem, lesion of
brucellosis, nervous system involvement with
Brudzinski's sign
carbon monoxide poisoning
carcinoma
carcinoma of breast
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, serial
cavernous sinus, syndrome
central nervous system, infection of
central pontine myelinolysis
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellar pontine angle tumor
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral infarction
cerebral peduncle
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident
cerebrovascular disease
cervical rib
cervical spine
cervical spondylosis
cervical spondylosis, differential diagnosis of
cervical spondylosis, misdiagnosis
chemotherapy, CNS treatment and complications with
children
chorioretinitis
cladribine
clemastine fumarate
Clinical Pathologic Conference(C.P.C.)
clinicoradiologic dissociation
collagen vascular disease
collapsin response mediator protein 5 IgG
complications
concentric sclerosis
confusion
contactin associated protein like 2 antibodies
controversies in neurology
cop 1
corpus callosum
corpus callosum, infarction of
corpus callosum, lesion of
corpus callosum, neoplasm of
cortical blindness
cost effectiveness
cranial neuropathy
cranial neuropathy, multiple
crying, pathologic
cryptococcal meningitis
cyclophosphamide
cyclosporine
cytomegalovirus infection
degenerative diseases of CNS
delirium
dementia
dementia, rapidly progressive
dementia, screening for
demyelinating disease
dermatomyositis
diabetes mellitus
diarrhea
differential diagnosis
diffuse axonal injury
disability rating scale, neurological
disability, neurological
disease modifying agents
drug abuse
drug induced neurologic disorders
dysarthria
dysphagia
dysphonia
efficacy
electroencephalogram, abnormalities of
electromyogram
emotional lability
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, paraneoplastic
encephalitis, viral
encephalomyelitis
encephalopathy
encephalopathy, Hashimoto's
encephalopathy, metabolic
epidemiology of neurology
episodic disorders
Epstein-Barr virus
evoked potentials
face, numbness of
facial nerve palsy
facial pain
facial weakness
facial weakness, bilateral
falling
familial
fever
fingolimod
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
ganglionitis
genu of corpus callosum
glioblastoma multiforme(astrocytoma Gr.III)
glioma
gliomatosis cerebri
glutamic acid decarboxylase, antibody
gray matter
Guillain Barre syndrome
head injury
headache
hearing loss
hemianopia, homonymous
hemifacial atrophy
hemiparesis
hemiplegia, progressive
herpes simplex encephalitis
herpes simplex encephalitis, diagnosis of
herpes simplex virus
herpes virus infection
herpes zoster
heterochromia iridis
highly active antiretroviral therapy
hippocampal atrophy
hippocampus
hippocampus, hyperintense
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
Horner's syndrome
Horner's syndrome, etiologies of
human immunodeficiency virus type 1
hydrocephalus
hyperreflexia
hypertension
hypertensive encephalopathy
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunocompetent
immunologic disease
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
impotence
inattention
infection
intellectual deficit
intellectual deterioration
interferon
interferon beta 1-a
interferon beta 1-b
intracerebral hemorrhage
Jakob-Creutzfeldt disease
JC virus
Kernig's sign
Klumpke palsy
laminectomy, cervical
laughing, pathologic
leucine rich glioma inactivated 1 antibodies
leukodystrophy
leukoencephalopathy
leukoencephalopathy, differential diagnosis
levamisole
level of consciousness, decreased
limbic encephalitis
lipoma of CNS
listeriosis, CNS
locked-in syndrome
lymphadenopathy
lymphadenopathy, hilar
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
malformation, vascular, cerebral
malignancy screen
malignancy, occult
Marchiafava-Bignami disease
memory, defect of recent
memory, impairment of
meningismus
meningitis
meningitis, aseptic
meningitis, chronic
mental status, abnormal
mesial temporal lobe
methotrexate
midbrain, lesion of
middle cerebellar peduncle
middle cerebellar peduncle, lesion
migraine
miosis
misdiagnosis
mitochondrial disease
mitoxantrone
monoclonal antibodies
mononeuritis multiplex
mononeuropathy
mononeuropathy multiplex
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, delayed
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, false negative
MRI, FLAIR
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, volumetry
MRS
multiple myeloma
multiple sclerosis
multiple sclerosis, benign form of
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
multiple sclerosis, tumefactive
mutism
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelopathy
myelopathy, ischemic
myelopathy, necrotizing
myelopathy, vacuolar
myoclonus
natalizumab
neoplasm, metastatic
neoplasm, metastatic to CNS
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurologic complications of, surgery
neurologic complications of, systemic disease
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic examination
neurologic practice
neurologic signs
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuropathology
neuropathy
neuropathy, paraneoplastic
neuropathy, peripheral
neuropathy, sensory
NMDA antagonists
ocrelizumab
onconeural antibodies
opportunistic infection
opportunistic infection, CNS
opsoclonus-myoclonus syndrome
otitis, neurologic complications with
palatal myoclonus
pancoast tumor
paraneoplastic cerebellar degeneration
paraparesis
paraparesis, spastic
paraproteinemia
paratrigeminal syndrome
peripheral nerve, lesion of
perseveration
personality change
phenylketonuria
placebo
plasmapheresis
PLEDs
PLEDs, bilateral independent
PLEDs, etiology of
pleocytosis of cerebrospinal fluid
poliomyelitis
polyneuropathy
posterior inferior cerebellar artery syndrome
posterior leukoencephalopathy syndrome
practice guidelines
precipitating factors
primary lateral sclerosis
prion disease
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
prosopagnosia
pseudobulbar palsy
psychological testing
psychomotor retardation
pulmonary nodules
pupil
pupil, abnormality in neurologic disorders
pyramidal tract
pyramidal tract dysfunction
quadriparesis
quadriplegia
quality of life
radiation therapy, CNS treatment and complications with
radiculitis
rapidly progressing neurologic illness
ReBUILD study
Red flags
rehabilitation for neurologic disorders
release phenomena
remote effect of cancer on the nervous system
remyelination
renal failure
retinopathy
retrovirus
review article
risk factors
Rosenthal fibers
saccadic eye movements, abnormal
safety
sarcoidosis
sarcoidosis, CNS
Schilder's disease
scleroderma
screening
seizure
seminoma
seronegative
shunt procedure, ventricular
shunt procedure, ventricular-complications of
sinusitis
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
spasticity
speech disorder
speech, loss of
spinal cord, compression of
spondylosis
steroid
steroid therapy, CNS treatment and complications with
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
symmetric brain lesions
syphilis, diagnosis and treatment
syphilis, neurologic complications with
syringomyelia
systemic lupus erythematosus
tau protein
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
Thies's sign
thrombocytopenia
thyroiditis
tongue, impaired movements of
tonsillectomy
toxic encephalopathy
toxoplasmosis, acquired
toxoplasmosis, CNS
transient neurologic deficit
treatment of neurologic disorder
trigeminal neuropathy
trigeminal neuropathy, sensory
tuberculosis
tumefactive lesion
tumor necrosis factor
tumor necrosis factor inhibitor
vaccination, neurologic complications with
vaccine
vasculitides
vasculopathy
vertebral-basilar insufficiency
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
visual loss
Waldenstrom's macroglobulinemia
walking, difficulty with
weight loss
West Nile fever
wheelchair
Whipple's disease
white matter disease
white matter, dirty-appearing
workup
xerophthalmia
xerostomia
Showing articles 800 to 850 of 9392 << Previous Next >>

Worsening Neurologic Symptoms in a Brain Tumor Patient
Neurol 85:e57-e61, Faivre, G.,et al, 2015

Clinicopathologic Conference, Borrelia Miyamotoi Infection and Possible Borrelia Burgdorferi Infection
NEJM 373:408-475, Case 24-2015, 2015

Outcome Following Decompressive Hemicraniectomy for Malignant Cerebral Infarction
Stroke 46:2695-26598, Honeybul, S.,et al, 2015

Oral Versus Intravenous High-Dose Methylprednisolone for Treatment of Relapses in Patients with Multiple Sclerosis (COPOUSEP):A Randomised, Controlled, Double-Blind,Non-Inferiority Trial
Lancet 386:974-981, LePage,E.,et al, 2015

A 27-Year Old Man with Rapidly Progressive Coma
Neurol 85:e74-e78, Wong,J.M.,et al, 2015

Recurrent Stroke in Childhood Cancer Survivors
Neurol 85:1056-1064, Fullerton, H.J.,et al, 2015

Treatment Outcomes with Rituximab in 100 Patients with Neuromyelitis Optica
JAMA Neurol 72:989-995, Kim, S.H.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Isolated Lingual Dyskinesia in Multiple Sclerosis
JAMA Neurol 72:1196-1197, Park, J.E.,et al, 2015

A 56-year-old Man with Cognitive Impairment and Difficulty Tying his Necktie
Neurol 85:e116-e122, Baker, J.M.,et al, 2015

Cryptococcal Meningoencephalitis in a Patient with Multiple Sclerosis Treated with Fingolimod
JAMA Neurol 72:1203-1205, Zhan, Y.,et al, 2015

Lafora Periodic Acid-Schiff Inclusion Bodies
Neurol 85:e130-e131, de Assis Franco, I.,et al, 2015

MRI Characteristics of Neuromyelitis Optica Spectrum Disorder
Neurol 84:1165-1173, Jin Kim, H.,et al, 2015

Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015

Very Late-Onset Neuromyelitis Optica Spectrum Disorder Beyond the Age of 75
J Neurol 262:1379-1384, Krumbholz, M.,et al, 2015

Molybdenum Cofactor Deficiency
Neurol 85:e175-e178, Nagappa, M.,et al, 2015

Acute Flaccid Myelitis of Unknown Etiology in California 2012-2015
JAMA 314:2663-2671, Van Haren, K.,et al, 2015

Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015

Clinical Features, Diagnosis, and Treatment of Disseminated Intravascular Coagulation in Adults
UptoDate, Leung, L.L.K., 2015

Antiplatelet Treatment Compared with Anticoagulation Treatment for Cervical Artery Dissection (CADISS): A Randomized Trial
Lancet Neurol 14:361-367, the CADISS Trial investigators, 2015

The Acquired Metabolic Disorders of the Nervous System, Ischemic-Hypoxic Encephalopathy
Adams & Victors Principles of Neurology Chp 40, pg 1133, Ropper, A.H.,et al, 2014

A 28-year-old Man with Progressive Gait Disturbance and Encephalopathy
Neurol 83:e204-e207, Massaro, A.M. & Pruitt, A., 2014

Opportunistic Infections of the Retina in Patients with Aquaporin-4 Antibody Disease
JAMA Neurol 71:1429-1432, George, J.S.,et al, 2014

Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 71:1372-1378, Huh, S.Y.,et al, 2014

CD49d Antisense Drug ATL1102 Reduces Disease Activity in Patients with Relapsing-Remitting MS
Neurol 83:1780-1788, Limmroth, V.,et al, 2014

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014

A 47-year-old Woman with Left Shoulder Pain after a Fall
Neurol 83:e112-e116, Jerath, N.U.,et al, 2014

Clinicopathologic Conference, Chronic Meningoencephalitis Consistent with Rasmussens Encephalitis
NEJM 371:1737-1746, Case 34-2014, 2014

Deep-Brain Stimulation - Entering the Era of Human Neural-Network Modulation
NEJM 371:1369-1373, Okun, M.S., 2014

Intensive Care Unit Admission in Multiple Sclerosis
Neurol 82:2112-2119, Marrie, R.A.,et al, 2014

Acoustic Apoplexy: An Acute Complication of a Common Intracranial Tumour
BMJ 348:g3268, Hollingworth, M.A.,et al, 2014

Balos Concentric Sclerosis
Lancet Neurol 13:740-746, Hardy, T.A. & Miller, D.H., 2014

A 69-Year-Old Man with Leukocytosis and Hemorrhagic Brain Lesions
Neurol 83:el-e5, Scott, K.M., et al, 2014

The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014

Motor Neurone Disease
BMJ 349:g4052, Nageshwaran, S.,et al, 2014

IgG4-Related Hypertrophic Pachymeningitis
JAMA Neurol 71:785-793, Lu, L.X.,et al, 2014

Cerebral Abnormalities in Adults with Ataxia-Telangiectasia
AJNR 35:119-123, Lin, D.D.M.,et al, 2014

Effects of Bacille Calmette-Guerin after the first Demyelinating event in the CNS
Neurol 82:41-48, Ristori, G.,et al, 2014

Addition of Hyperacute MRI Aids in Patient Selection, Decreasing the Use of Endovascular Stroke Therapy
Stroke 45:467-472, Wisco, D.,et al, 2014

Clinicopathologic Conference, Infective Endocarditis and Infectious Aortitis due to Staphylococcus Aureus
NEJM 370:651-660, Case 5-2014, 2014

Mycophenolate Mofetil in Multiple Sclerosis: A Multicentre Retrospective Study on 344 Patients
JNNP 85:279-283,246, Michel, L.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis
NEJM 370:792-794, McMinn, P.C., 2014

Relapsing-Remitting Tumefactive Demyelination
JAMA Neurol 71:366-367, Brandao, E.,et al, 2014

Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
NEJM 370:911-920, Zhou, Q.,et al, 2014

Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014

Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:1083-1092, Yadav, V.,et al, 2014

Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:e103-e104, Fox, R.J., 2014

Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial
Lancet 383:2213-2221, Chataway, J.,et al, 2014



Showing articles 800 to 850 of 9392 << Previous Next >>